Acrolein adducts and responding autoantibodies correlate with metabolic disturbance in Alzheimer’s disease

Medicine and Dentistry

• Water-Electrolyte Imbalance 100%
• Alzheimer's Disease 100%
• Autoantibodies 100%
• Acrolein 100%
• Metabolic Syndrome 50%
• Biological Marker 11%
• Immunoglobulin M 11%
• In Vitro 5%
• Hyperglycemia 5%
• Enzyme Linked Immunosorbent Assay 5%
• Diagnosis 5%
• Immunoprecipitation 5%
• Disease Model 5%
• Adduction 5%
• Dyslipidemia 5%
• High Density Lipoprotein Cholesterol 5%
• Triacylglycerol 5%
• Amyloid Beta 5%
• Carboxy Terminal Sequence 5%
• Histochemistry 5%
• Amyloid Precursor Protein 5%
• Immunotherapy 5%
• Antibodies 5%
• Immunoblotting 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Metabolic Disorder 100%
• Acrolein 100%
• Autoantibodies 100%
• Alzheimer's Disease 100%
• Metabolic Syndrome X 50%
• Biological Marker 11%
• Immunoglobulin M 11%
• Enzyme-Linked Immunosorbent Assay 5%
• Western Blot 5%
• Mouse 5%
• Immunoprecipitation 5%
• Mouse Model 5%
• Triacylglycerol 5%
• High Density Lipoprotein Cholesterol 5%
• Hyperglycemia 5%
• Disease Model 5%
• Antibodies 5%
• Amyloid 5%
• Dyslipidemia 5%
• Immunotherapy 5%
• Amyloid Precursor Protein 5%

Neuroscience

• Alzheimer's Disease 100%
• Autoantibodies 100%
• Immunoglobulin M 11%
• In Vitro 5%
• Western Blot 5%
• Antibodies 5%
• C-Terminus 5%
• Hyperglycemia 5%
• ELISA 5%
• High Density Lipoprotein Cholesterol 5%
• Beta Amyloid 5%
• Triacylglycerol 5%
• Amyloid Precursor Protein 5%
• Immunoprecipitation 5%
• Metabolic Pathway 5%
• Dyslipidemia 5%
• Histochemistry 5%
• Immunotherapy 5%